Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2006
06/21/2006CN1791595A 溴化物及其晶体 Bromides and Crystal
06/21/2006CN1791583A 2-substituted pyrimidines.
06/21/2006CN1791580A Biaryl substituted 6-membered heterocyles as sodium channel blockers
06/21/2006CN1791576A Benzamide modulators of metabotropic glutamate receptors
06/21/2006CN1791575A Cyanofluoropyrrolidine derivative.
06/21/2006CN1791572A Novel compounds
06/21/2006CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK
06/21/2006CN1789264A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
06/21/2006CN1789250A Optical antimer of a group of nitro imidazole derivatives, preparation method and uses thereof
06/21/2006CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/21/2006CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists
06/20/2006US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
06/20/2006US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease
06/20/2006US7064211 Hemiasterlin derivatives and uses thereof
06/20/2006US7064201 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
06/20/2006US7064144 Imidazole derivatives as adenosine deaminase inhibitors
06/20/2006US7064142 Imidazonline compounds
06/20/2006US7064136 Central nervous system disorders; psychological disorders; schizophrenia; antiarthritic agents; Alzheimer's disease; anticancer agents
06/20/2006US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity
06/20/2006US7064129 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life
06/20/2006US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
06/20/2006US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition
06/20/2006CA2121523C Sulfonamide derivatives
06/15/2006WO2006063293A2 THIOUREAS AS FACTOR Xa INHIBITORS
06/15/2006WO2006063113A2 Ureas as factor xa inhibitors
06/15/2006WO2006062876A2 Estrogen receptor modulators
06/15/2006WO2006062478A1 Novel treatment of gastrointestinal disorders
06/15/2006WO2006062069A1 REMEDY FOR PRURITUS COMPRISING p38MAP KINASE AS THE ACTIVE INGREDIENT
06/15/2006WO2006062062A1 Organic compound, charge-transporting material, and organic electroluminescent element
06/15/2006WO2006061585A1 Pyrrolidine compounds
06/15/2006WO2006061212A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
06/15/2006WO2006061147A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
06/15/2006WO2006061116A1 Pyrazine dicarboxamides and the use thereof
06/15/2006WO2006061074A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
06/15/2006WO2006026196A3 Androgen receptor modulators
06/15/2006WO2006026135A3 Substituted biaryl piperazinyl-pyridine analogues
06/15/2006WO2005097112A3 Ion channel modulators
06/15/2006WO2005056535A8 1,2,3-triazole amide derivatives as inhibitors of cytokine production
06/15/2006US20060128968 A novel intermediate, 2-butyl-3-(4'bromobenzyl)-1,3-diazaspiro[4.4]non-1-ene-4-one; a Suzuki coupling reaction with a protected imidazolephenylboronic acid will give irbesartan
06/15/2006US20060128967 a chemical intermediate to irbesartan, by reacting a valerimidate derivative with a first amine using acid catalyst, cooling, reacting with a second amine and second acid catalyst, heating to reflux, contacting with base, phase separation and recovery
06/15/2006US20060128965 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid
06/15/2006US20060128964 Method for preparing 2- (2-pyridylmethylsulphinyl) benzimidazoles
06/15/2006US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists
06/15/2006US20060128961 Process for the production of meso-substituted cyanine dyes
06/15/2006US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
06/15/2006US20060128785 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers
06/15/2006US20060128783 Tyrosine kinase inhibitors
06/15/2006US20060128766 Triazole substituted aminobenzophenone compounds
06/15/2006US20060128761 Novel triazole compounds as transforming growth factor (TGF) inhibitors
06/15/2006US20060128758 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
06/15/2006US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea;
06/15/2006US20060128724 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
06/15/2006US20060128722 Indoles useful in the treatment of androgen-receptor related diseases
06/15/2006US20060128718 Tetrahydropyridazine derivatives having a pesticidal effect
06/15/2006US20060128717 Therapeutic agents useful for treating pain
06/15/2006US20060128712 Phenyl-piperazine methanone derivatives, substituted by heterocyclic groups
06/15/2006US20060128706 Apoptosis promoters
06/15/2006US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
06/15/2006US20060128692 Non nucleoside reverse transcriptase inhibitors
06/15/2006US20060128687 Lactam glycogen phosphorylase inhibitors and method of use
06/15/2006US20060128685 Pyrazole derivative
06/15/2006US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use
06/15/2006US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
06/15/2006US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
06/15/2006US20060128568 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazoles and their use as herbicides
06/15/2006US20060127930 A solid surface linked by NH, CO, NHCO, C(O)NH, CH2, sulfur, or an oxygen to a triazine molecule which is covalently linked to an oligonucleotide or biologically active polymer
06/15/2006US20060127404 Hinge core mimetibodies, compositions, methods and uses
06/15/2006US20060123565 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
06/15/2006CA2594102A1 Pyrazine dicarboxamides and the use thereof
06/15/2006CA2590811A1 Heterocycle derivatives as histone deacetylase (hdac) inhibitors
06/15/2006CA2590078A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
06/15/2006CA2589274A1 Inhibitors of protein kinases
06/15/2006CA2589271A1 Urea inhibitors of map kinases
06/15/2006CA2589127A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
06/15/2006CA2588148A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
06/14/2006EP1669069A1 Compounds effecting glukokinase
06/14/2006EP1669068A1 Compounds effecting Glucokinase
06/14/2006EP1667998A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
06/14/2006EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof
06/14/2006EP1667996A1 Quinazoline derivatives
06/14/2006EP1667995A1 Benzimidazole acetonitriles
06/14/2006EP1667994A1 Quinolone antibacterial agents
06/14/2006EP1667990A2 New compounds
06/14/2006EP1667969A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors
06/14/2006EP1667962A1 Aminoalkylamide substituted cyclohexyl derivatives
06/14/2006EP1667959A1 Biphenyloxy-acids
06/14/2006EP1667679A1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
06/14/2006EP1667675A1 Entry inhibitors of the hiv virus
06/14/2006EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/14/2006EP1587877B1 Beta-isoindigo coloring agent
06/14/2006EP1567507B1 1,2,3- triazole amide derivatives as cytokine inhibitors
06/14/2006EP1506190B1 (imidazol-1-yl-methyl)-pyridazine as nmda receptor blocker
06/14/2006EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
06/14/2006EP1341759B1 3-substituted oxindole beta 3 agonists
06/14/2006EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
06/14/2006EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
06/14/2006CN1788003A Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
06/14/2006CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
06/14/2006CN1788000A Phthalazinone derivatives
06/14/2006CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers